openPR Logo
Press release

The Market For Gene Therapy Is Likely To Be Valued At US$ 10.1 Billion by 2032

11-09-2022 05:25 PM CET | Health & Medicine

Press release from: Fact.MR

Gene Therapy Market

Gene Therapy Market

Over the last few years, the world has seen a significant increase in focus on health care, which has resulted in a massive increase in research and development activities. The rising prevalence of rare diseases has also increased the demand for novel treatments, which has driven gene therapy market potential in the past. A CAGR of 18.7% was recorded for the market from 2015 to 2021.

The increasing use of gene modification in a variety of treatments, as well as the increasing use of genome editing in biotechnology applications, are also expected to guide the gene therapy market in the coming years. The global gene therapy industry is expected to be hampered by high gene therapy costs and a lack of standardization. From 2022 to 2032, demand for gene therapies is expected to grow at an astronomical CAGR of 18.5%.

๐—–๐—น๐—ถ๐—ฐ๐—ธ ๐—›๐—ฒ๐—ฟ๐—ฒ ๐—ง๐—ผ ๐—ด๐—ฒ๐˜ ๐—ฎ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—œ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ถ๐—ป๐—ด ๐—™๐˜‚๐—น๐—น ๐—ง๐—ข๐—–, ๐—ง๐—ฎ๐—ฏ๐—น๐—ฒ & ๐—™๐—ถ๐—ด๐˜‚๐—ฟ๐—ฒ๐˜€): ๐—ต๐˜๐˜๐—ฝ๐˜€://๐˜„๐˜„๐˜„.๐—ณ๐—ฎ๐—ฐ๐˜๐—บ๐—ฟ.๐—ฐ๐—ผ๐—บ/๐—ฐ๐—ผ๐—ป๐—ป๐—ฒ๐—ฐ๐˜๐˜‚๐˜€/๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ?๐—ณ๐—น๐—ฎ๐—ด=๐—ฆ&๐—ฟ๐—ฒ๐—ฝ_๐—ถ๐—ฑ=๐Ÿฐ๐Ÿฒ๐Ÿฐ๐Ÿด

๐—ฃ๐—ฟ๐—ผ๐—บ๐—ถ๐—ป๐—ฒ๐—ป๐˜ ๐—š๐—ฒ๐—ป๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€

Research and development (R&D) activities are also expected to have a significant impact on the market. Several companies are aiming to build a gene therapy platform with a strategy centered on establishing a transformational portfolio through in-house capabilities and enhancing those capabilities through strategic collaborations, R&D expansion, and potential licensing, merger, and acquisition activities.
For example, the Cystic Fibrosis Foundation announced an investment in SalioGen Therapeutics in January 2022 to support the company's preclinical research into novel gene therapy for cystic fibrosis. SalioGen's Gene Coding approach is intended to activate, deactivate, or modify the function of any gene in the genome.

๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—š๐—ฒ๐—ป๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

By Product :
โ€ข Yescarta-based Gene Therapy
โ€ข Kymriah-based Gene Therapy
โ€ข Luxturna-based Gene Therapy
โ€ข Strimvelis-based Gene Therapy
โ€ข Gendicine
โ€ข Others

By Application :
โ€ข Ophthalmology
โ€ข Oncology
โ€ข Adenosine Deaminase/Deficient Severe Combined Immunodeficiency (ADA-SCID)

By Region :
โ€ข North America
โ€ข Latin America
โ€ข Europe
โ€ข East Asia
โ€ข South Asia
โ€ข MEA

๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฐ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ ๐—”๐—ฐ๐—ฐ๐—ผ๐˜‚๐—ป๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐—ฆ๐—ถ๐˜‡๐—ฎ๐—ฏ๐—น๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ต๐—ฎ๐—ฟ๐—ฒ ๐—ฏ๐˜† ๐—”๐—ฝ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป

The cancer segment is expected to account for a sizable portion of the market. The increasing burden of cancer disorder, the growing emphasis on research to develop an effective cancer treatment, and rising cancer research investments are all factors driving the segment growth.
According to Globocan 2020, an estimated 19,292,789 new cancer cases and 9,958,133 cancer deaths were reported worldwide in 2020. Various gene therapy strategies are currently being used in the treatment of cancer. These include anti-angiogenic gene therapy, pro-drug activating suicide gene therapy, immune modulation based on gene therapy, oncolytic virotherapy, gene defect correction/compensation, antisense, genetic manipulation of apoptotic and tumor invasion pathways, and RNAi strategies. These therapies have targeted cancer types such as lung, brain, breast, pancreatic, liver, colorectal, prostate, bladder, head and neck, skin, renal and ovarian cancer.

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—–๐—ผ๐˜‚๐—ป๐˜๐—ฟ๐˜† - ๐—ต๐˜๐˜๐—ฝ๐˜€://๐˜„๐˜„๐˜„.๐—ณ๐—ฎ๐—ฐ๐˜๐—บ๐—ฟ.๐—ฐ๐—ผ๐—บ/๐—ฐ๐—ผ๐—ป๐—ป๐—ฒ๐—ฐ๐˜๐˜‚๐˜€/๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ?๐—ณ๐—น๐—ฎ๐—ด=๐—ฅ๐—–&๐—ฟ๐—ฒ๐—ฝ_๐—ถ๐—ฑ=๐Ÿฐ๐Ÿฒ๐Ÿฐ๐Ÿด

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

The global gene therapy market is fiercely competitive, with only a few major players. Companies like Amgen Inc., Bluebird Bio, Gilead Sciences, Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd., Spark Therapeutics (Roche AG), and UniQure N.V., have a sizable market share in the Gene Therapy market. To secure a position in the global market, various strategic alliances such as collaborations, acquisitions, and the launch of advanced products have been formed.
โ€ข In October 2021, the National Institutes of Health, the United States Food and Drug Administration, ten pharmaceutical companies, and five non-profit organizations announced a collaboration to accelerate the development of gene therapies for the 30 million Americans who suffer from a rare disease. Such initiatives are expected to boost demand for gene therapy.
โ€ข BioMarin Pharmaceutical Inc. reported updates on its investigational gene therapy programs in clinical development in February 2022. The Food and Drug Administration (FDA) issued additional requests to the Company for information needed to resolve the clinical hold of the PHEARLESS Phase 1/2 study of BMN 307 issued in September 2021.
โ€ข Novartis acquired Gyroscope Therapeutics in December 2021, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness.
โ€ข Abecma (idecabtagene vicleucel), a cell-based gene therapy, was approved by the US Food and Drug Administration in March 2021 to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy. Abecma is the first FDA-approved cell-based gene therapy for the treatment of multiple myeloma.

๐—ž๐—ฒ๐˜† ๐—–๐—ต๐—ฎ๐—น๐—น๐—ฒ๐—ป๐—ด๐—ฒ๐˜€ ๐—ฃ๐—ฟ๐—ฒ๐˜ƒ๐—ฎ๐—น๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—š๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—š๐—ฒ๐—ป๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

Gene therapies are expensive medical procedures that necessitate significant capital investment on the part of both the provider and the patient, which limits the global gene therapy market's growth.
Gene modifications necessitate precision equipment, which significantly raises the cost of cell and gene therapy and limits the global adoption of these therapies. Due to high costs and low adoption, viral vector gene therapies are expected to grow at the slowest rate.

๐—™๐—ผ๐—ฟ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€:

https://www.prnewswire.com/news-releases/six-out-of-every-ten-ariel-work-platform-sold-worldwide-is-reported-from-asia-pacific-301411893.html

https://www.prnewswire.com/news-releases/as-investment-in-road-infrastructure-grows-recycled-asphalt-market-will-be-positioned-to-surpass-us-10-7-bn-by-2031--301412860.html

https://www.prnewswire.com/news-releases/aviation-lubricants-market-to-grow-by-1-6x-as-air-passenger-traffic-burgeons-post-pandemic-301414179.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Market For Gene Therapy Is Likely To Be Valued At US$ 10.1 Billion by 2032 here

News-ID: 2800409 • Views: โ€ฆ

More Releases from Fact.MR

Well Intervention Market is Predicted to Reach US$ 17.1 Billion by 2035, Expanding at a CAGR of 7% | Fact.MR
Well Intervention Market is Predicted to Reach US$ 17.1 Billion by 2035, Expandi โ€ฆ
The global well intervention market is projected to increase from USD 8.7 billion in 2025 to USD 17.1 billion by 2035, with a compound annual growth rate (CAGR) of 7.0% during the forecast period. Growth is driven by the growing need for energy, along with aging oil and gas wells. Offshore rig operators are stepping up their game by investing in both light and heavy intervention services to enhance efficiencyโ€ฆ
Assembly Robot Market Size Worth US$ 54,915.6 Million by 2035 at a CAGR Of 11.6% | Fact.MR
Assembly Robot Market Size Worth US$ 54,915.6 Million by 2035 at a CAGR Of 11.6% โ€ฆ
The global assembly robot market is projected to rise from USD 18,325.4 million in 2025 to USD 54,915.6 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 11.6% during the forecast period. This growth is fueled by advancements in artificial intelligence, machine learning, and 5G technology, which enhance robots' precision, efficiency, and safety, particularly in collaborative operations alongside human workers. These innovations allow assembly robots to execute complexโ€ฆ
Zonal Isolation Packers Market is Predicted to Reach US$ 4.6 Billion by 2035, Expanding at a CAGR of 5.1% | Fact.MR
Zonal Isolation Packers Market is Predicted to Reach US$ 4.6 Billion by 2035, Ex โ€ฆ
The global zonal isolation packers market is projected to increase from USD 2.8 billion by 2025 to USD 4.6 billion by 2035, with a CAGR of 5.1% during the forecast period. Growth is driven by rising focus on well integrity during drilling and production, which has accelerated the use of mechanical and swellable packers. Operators are adopting zonal isolation systems to prevent cross-zone fluid migration and ensure long-term performance. The riseโ€ฆ
Lithium-Ion Battery Pack Market Size Expected to Reach US$ 92.8 Billion by 2035: Fact.MR Report
Lithium-Ion Battery Pack Market Size Expected to Reach US$ 92.8 Billion by 2035: โ€ฆ
The global lithium-ion (Li-ion) battery pack market is poised for significant growth, with projections indicating an increase from USD 66.4 billion in 2025 to USD 92.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of 3.4% during the forecast period. This expansion is largely driven by the rising adoption of electric vehicles (EVs), advances in renewable energy storage solutions, and ongoing innovations in battery technology. For More Insights into theโ€ฆ

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene โ€ฆ
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valuedโ€ฆ
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther โ€ฆ
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88โ€ฆ
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy โ€ฆ
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases byโ€ฆ
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma โ€ฆ
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells withโ€ฆ
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In โ€ฆ
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,โ€ฆ
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische โ€ฆ
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goalโ€ฆ